Income Tax Expense (Benefit) in USD of Endo International plc from 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Endo International plc quarterly/annual Income Tax Expense (Benefit) history and change rate from 2012 to Q4 2023.
  • Endo International plc Income Tax Expense (Benefit) for the quarter ending 31 Dec 2023 was $28.8M, a 423% increase year-over-year.
  • Endo International plc Income Tax Expense (Benefit) for the twelve months ending 31 Dec 2023 was $55.9M, a 160% increase year-over-year.
  • Endo International plc annual Income Tax Expense (Benefit) for 2023 was $55.9M, a 160% increase from 2022.
  • Endo International plc annual Income Tax Expense (Benefit) for 2022 was $21.5M, a 4.28% decline from 2021.
  • Endo International plc annual Income Tax Expense (Benefit) for 2021 was $22.5M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

Endo International plc Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $55.9M $28.8M +$23.3M +423% 01 Oct 2023 31 Dec 2023 10-K 06 Mar 2024
Q3 2023 $32.6M $11M +$362K +3.39% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2023
Q2 2023 $32.2M $10.3M +$3.13M +43.7% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2023
Q1 2023 $29.1M $5.77M +$7.59M 01 Jan 2023 31 Mar 2023 10-Q 08 May 2023
Q4 2022 $21.5M $5.5M -$3.61M -39.6% 01 Oct 2022 31 Dec 2022 10-K 06 Mar 2024
Q3 2022 $25.1M $10.7M +$9.13M +590% 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023
Q2 2022 $16M $7.15M -$3.95M -35.6% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 $19.9M -$1.82M -$2.54M -351% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023
Q4 2021 $22.5M $9.11M +$159M 01 Oct 2021 31 Dec 2021 10-K 06 Mar 2024
Q3 2021 -$136M $1.55M -$2.63M -62.9% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 -$133M $11.1M +$3.46M +45.3% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 -$137M $724K +$137M 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022
Q4 2020 -$274M -$149M -$133M -831% 01 Oct 2020 31 Dec 2020 10-K 06 Mar 2023
Q3 2020 -$141M $4.17M -$13.2M -76% 01 Jul 2020 30 Sep 2020 10-Q 05 Nov 2021
Q2 2020 -$127M $7.64M +$4.17M +120% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021
Q1 2020 -$132M -$136M -$147M -1350% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021
Q4 2019 $15.7M -$16.1M -$14.3M -795% 01 Oct 2019 31 Dec 2019 10-K 01 Mar 2022
Q3 2019 $29.9M $17.4M +$14.4M +478% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020
Q2 2019 $15.6M $3.47M -$2.77M -44.4% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020
Q1 2019 $18.3M $10.9M -$4.59M -29.6% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020
Q4 2018 $22.9M -$1.79M +$151M +98.8% 01 Oct 2018 31 Dec 2018 10-K 26 Feb 2021
Q3 2018 -$128M $3M +$31.1M 01 Jul 2018 30 Sep 2018 10-Q 04 Nov 2019
Q2 2018 -$159M $6.24M +$63.7M 01 Apr 2018 30 Jun 2018 10-Q 05 Aug 2019
Q1 2018 -$223M $15.5M +$27.4M 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019
Q4 2017 -$250M -$153M -$80.5M -111% 01 Oct 2017 31 Dec 2017 10-K 26 Feb 2020
Q3 2017 -$170M -$28.1M -$74.3M -161% 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018
Q2 2017 -$95.5M -$57.5M +$498M +89.6% 01 Apr 2017 30 Jun 2017 10-Q 08 Aug 2018
Q1 2017 -$593M -$11.9M +$107M +90% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018
Q4 2016 -$700M -$72.3M +$725M +90.9% 01 Oct 2016 31 Dec 2016 10-K 28 Feb 2019
Q3 2016 -$1.42B $46.2M +$207M 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017
Q2 2016 -$1.63B -$555M -$543M -4265% 01 Apr 2016 30 Jun 2016 10-Q 08 Aug 2017
Q1 2016 -$1.09B -$119M +$48.2M +28.9% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017
Q4 2015 -$1.14B -$797M -$788M -8393% 01 Oct 2015 31 Dec 2015 8-K 08 May 2018
Q3 2015 -$350M -$161M -$191M -634% 01 Jul 2015 30 Sep 2015 10-Q 08 Nov 2016
Q2 2015 -$159M -$12.7M -$17.5M -365% 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016
Q1 2015 -$141M -$167M -$180M -1414% 01 Jan 2015 31 Mar 2015 10-Q 06 May 2016
Q4 2014 $38.3M -$9.38M -$70.2M -115% 01 Oct 2014 31 Dec 2014 10-K 01 Mar 2017
Q3 2014 $108M $30.1M -$14.5M -32.5% 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015
Q2 2014 $123M $4.81M -$24.2M -83.4% 01 Apr 2014 30 Jun 2014 10-Q 10 Aug 2015
Q1 2014 $147M $12.7M +$3.45M +37.3% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015
Q4 2013 $144M $60.8M 01 Oct 2013 31 Dec 2013 10-K 29 Feb 2016
Q3 2013 $44.7M 01 Jul 2013 30 Sep 2013 10-Q 10 Nov 2014
Q2 2013 $29M 01 Apr 2013 30 Jun 2013 10-Q 04 Aug 2014
Q1 2013 $9.25M 01 Jan 2013 31 Mar 2013 10-Q 09 May 2014

Endo International plc Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $55.9M +$34.3M +160% 01 Jan 2023 31 Dec 2023 10-K 06 Mar 2024
2022 $21.5M -$962K -4.28% 01 Jan 2022 31 Dec 2022 10-K 06 Mar 2024
2021 $22.5M +$296M 01 Jan 2021 31 Dec 2021 10-K 06 Mar 2024
2020 -$274M -$290M -1847% 01 Jan 2020 31 Dec 2020 10-K 06 Mar 2023
2019 $15.7M -$7.26M -31.6% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022
2018 $22.9M +$273M 01 Jan 2018 31 Dec 2018 10-K 26 Feb 2021
2017 -$250M +$450M +64.2% 01 Jan 2017 31 Dec 2017 10-K 26 Feb 2020
2016 -$700M +$437M +38.5% 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2019
2015 -$1.14B -$1.18B -3072% 01 Jan 2015 31 Dec 2015 8-K 08 May 2018
2014 $38.3M -$105M -73.4% 01 Jan 2014 31 Dec 2014 10-K 01 Mar 2017
2013 $144M +$105M +270% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016
2012 $38.8M 01 Jan 2012 31 Dec 2012 8-K 02 Jun 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.